229 related articles for article (PubMed ID: 28900136)
1. Differential effects of soluble and aggregating polyQ proteins on cytotoxicity and type-1 myosin-dependent endocytosis in yeast.
Berglund LL; Hao X; Liu B; Grantham J; Nyström T
Sci Rep; 2017 Sep; 7(1):11328. PubMed ID: 28900136
[TBL] [Abstract][Full Text] [Related]
2. Exploding the Repeat Length Paradigm while Exploring Amyloid Toxicity in Huntington's Disease.
Wetzel R
Acc Chem Res; 2020 Oct; 53(10):2347-2357. PubMed ID: 32975927
[TBL] [Abstract][Full Text] [Related]
3. Multiple discrete soluble aggregates influence polyglutamine toxicity in a Huntington's disease model system.
Xi W; Wang X; Laue TM; Denis CL
Sci Rep; 2016 Oct; 6():34916. PubMed ID: 27721444
[TBL] [Abstract][Full Text] [Related]
4. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease.
Chen M; Wolynes PG
Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517
[TBL] [Abstract][Full Text] [Related]
5. Wild type huntingtin toxicity in yeast: Implications for the role of amyloid cross-seeding in polyQ diseases.
Alexandrov AI; Serpionov GV; Kushnirov VV; Ter-Avanesyan MD
Prion; 2016 May; 10(3):221-7. PubMed ID: 27220690
[TBL] [Abstract][Full Text] [Related]
6. Polyglutamine tracts regulate beclin 1-dependent autophagy.
Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC
Nature; 2017 May; 545(7652):108-111. PubMed ID: 28445460
[TBL] [Abstract][Full Text] [Related]
7. Generation and Characterization of Knock-in Mouse Models Expressing Versions of Huntingtin with Either an N17 or a Combined PolyQ and Proline-Rich Region Deletion.
André EA; Braatz EM; Liu JP; Zeitlin SO
J Huntingtons Dis; 2017; 6(1):47-62. PubMed ID: 28211815
[TBL] [Abstract][Full Text] [Related]
8. [Protein-Protein Interactions of Huntingtin in the Hippocampus].
Proskura AL; Vechkapova SO; Zapara TA; Ratushniak AS
Mol Biol (Mosk); 2017; 51(4):734-742. PubMed ID: 28900094
[TBL] [Abstract][Full Text] [Related]
9. Modulation of mutant Huntingtin aggregates and toxicity by human myeloid leukemia factors.
Banerjee M; Datta M; Bhattacharyya NP
Int J Biochem Cell Biol; 2017 Jan; 82():1-9. PubMed ID: 27840155
[TBL] [Abstract][Full Text] [Related]
10. Aggregation of expanded polyglutamine domain in yeast leads to defects in endocytosis.
Meriin AB; Zhang X; Miliaras NB; Kazantsev A; Chernoff YO; McCaffery JM; Wendland B; Sherman MY
Mol Cell Biol; 2003 Nov; 23(21):7554-65. PubMed ID: 14560003
[TBL] [Abstract][Full Text] [Related]
11. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
[TBL] [Abstract][Full Text] [Related]
12. Pathological polyQ expansion does not alter the conformation of the Huntingtin-HAP40 complex.
Huang B; Guo Q; Niedermeier ML; Cheng J; Engler T; Maurer M; Pautsch A; Baumeister W; Stengel F; Kochanek S; Fernández-Busnadiego R
Structure; 2021 Aug; 29(8):804-809.e5. PubMed ID: 33909994
[TBL] [Abstract][Full Text] [Related]
13. Effects of flanking sequences and cellular context on subcellular behavior and pathology of mutant HTT.
Chongtham A; Bornemann DJ; Barbaro BA; Lukacsovich T; Agrawal N; Syed A; Worthge S; Purcell J; Burke J; Chin TM; Marsh JL
Hum Mol Genet; 2020 Mar; 29(4):674-688. PubMed ID: 31943010
[TBL] [Abstract][Full Text] [Related]
14. Huntingtin affinity for partners is not changed by polyglutamine length: aggregation itself triggers aberrant interactions.
Davranche A; Aviolat H; Zeder-Lutz G; Busso D; Altschuh D; Trottier Y; Klein FA
Hum Mol Genet; 2011 Jul; 20(14):2795-806. PubMed ID: 21518730
[TBL] [Abstract][Full Text] [Related]
15. Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models.
Ehrnhoefer DE; Duennwald M; Markovic P; Wacker JL; Engemann S; Roark M; Legleiter J; Marsh JL; Thompson LM; Lindquist S; Muchowski PJ; Wanker EE
Hum Mol Genet; 2006 Sep; 15(18):2743-51. PubMed ID: 16893904
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into the aggregation mechanism of huntingtin exon 1 protein fragment with different polyQ-lengths.
Priya SB; Gromiha MM
J Cell Biochem; 2019 Jun; 120(6):10519-10529. PubMed ID: 30672003
[TBL] [Abstract][Full Text] [Related]
17. Folding Landscape of Mutant Huntingtin Exon1: Diffusible Multimers, Oligomers and Fibrils, and No Detectable Monomer.
Sahoo B; Arduini I; Drombosky KW; Kodali R; Sanders LH; Greenamyre JT; Wetzel R
PLoS One; 2016; 11(6):e0155747. PubMed ID: 27271685
[TBL] [Abstract][Full Text] [Related]
18. Amplification of neurotoxic HTTex1 assemblies in human neurons.
Chongtham A; Isas JM; Pandey NK; Rawat A; Yoo JH; Mastro T; Kennedy MB; Langen R; Khoshnan A
Neurobiol Dis; 2021 Nov; 159():105517. PubMed ID: 34563643
[TBL] [Abstract][Full Text] [Related]
19. A Targetable Self-association Surface of the Huntingtin exon1 Helical Tetramer Required for Assembly of Amyloid Pre-nucleation Oligomers.
Mishra R; Gerlach GJ; Sahoo B; Camacho CJ; Wetzel R
J Mol Biol; 2024 Jun; 436(12):168607. PubMed ID: 38734203
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional profiles for distinct aggregation states of mutant Huntingtin exon 1 protein unmask new Huntington's disease pathways.
Moily NS; Ormsby AR; Stojilovic A; Ramdzan YM; Diesch J; Hannan RD; Zajac MS; Hannan AJ; Oshlack A; Hatters DM
Mol Cell Neurosci; 2017 Sep; 83():103-112. PubMed ID: 28743452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
